Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection
Journal
Oncotarget
Journal Volume
8
Journal Issue
38
Pages
63715
Date Issued
2017-09-08
Abstract
Malignant primary brain tumors are one of the most aggressive cancers. Pretreatment serum nonneuronal biomarkers closely associated with postoperative outcomes are of high clinical relevance. The present study aimed to identify potential pretreatment serum biomarkers that may influence oncological outcomes in patients with primary brain tumors.
Subjects
brain tumor; glioma; lactate; prognostic factor; tumor marker
Brain tumor; Glioma; Lactate; Prognostic factor; Tumor marker
SDGs
Other Subjects
glial fibrillary acidic protein; lactate dehydrogenase; lactic acid; neuron specific enolase; neutrophil gelatinase associated lipocalin; protein S100B; tumor marker; adult; Article; brain surgery; brain tumor; cancer grading; cancer prognosis; cancer surgery; cancer survival; cohort analysis; controlled study; diagnostic test accuracy study; female; human; lactate blood level; major clinical study; male; overall survival; progression free survival; receiver operating characteristic; survival analysis
Publisher
IMPACT JOURNALS LLC
Type
journal article